Pacific Biosciences of California Inc
XBER:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
XBER:P09
|
US |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
E
|
EDP Energias de Portugal SA
XBER:EDP
|
PT |
|
APA Corp (US)
F:2S3
|
US |
|
GAIL (India) Ltd
OTC:GAILF
|
IN |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
|
PureTech Health PLC
F:0VQ
|
US |
|
FirstRand Ltd
OTC:FANDF
|
ZA |
|
T
|
Tesco PLC
BMV:TSCON
|
UK |
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
|
Acconeer AB
F:2LU
|
SE |
|
S
|
Sirius XM Holdings Inc
XMUN:RDO
|
US |
|
Severn Trent PLC
F:SVT
|
UK |
|
T
|
Terna Rete Elettrica Nazionale SpA
OTC:TERRF
|
IT |
Shareholder Yield
Current shareholder yield for 
P09 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
P09 Price
Pacific Biosciences of California Inc
| Average Annual Return | -36.34% |
| Standard Deviation of Annual Returns | 42.46% |
| Max Drawdown | -97% |
| Market Capitalization | 425.4m EUR |
| Shares Outstanding | 2 701 732 156 |
| Percentage of Shares Shorted |
N/A
|
